• In the first year, students will study the fundamentals of biochemistry and cell biology, which are required to understand the technologies used in the early stages of new medicine development. Case studies will look at the challenges of creating new medicines, disease states, and the ethical considerations of working in the biopharmaceutical industry.
  • The second-year examines the intricate signaling structures within the human body and looks at the immune memory that new vaccines seek to stimulate. In addition, students will be required to consider the commercialization of new medicines and will develop their knowledge of intellectual property and how to manage it in a global market.
  • The research project is a core component of the third year, along with modules in business planning and the bioprocessing of new medicines. At least one optional module is offered every year of the program, enabling students to tailor their degree towards the business side of the new medicines industry or the biomolecular side.
  • Upon successful completion of 360 credits, students will be awarded a BSc (Hons) in Bioprocessing of New Medicines (Science and Engineering).